Literature DB >> 24706432

Plasma glucose measurement in diabetes: impact and implications of variations in sample collection procedures with a focus on the first hour after sample collection.

Huan Chan, Helen Lunt, Harmony Thompson, Helen F Heenan, Christopher M A Frampton, Christopher M Florkowski.   

Abstract

BACKGROUND: Previous studies of participants with plasma glucose concentrations at or near the glucose reference range demonstrate glucose loss following delayed separation and extraction of plasma from the cellular components of blood, of ≤7% per hour. We aimed to assess pre-analytical glucose loss in diabetic subjects, focusing on the first hour after sample collection.
METHODS: Venous blood was collected from diabetes clinic attendees, into a series of lithium heparin PST™ (plasma separator tube) and fluoride oxalate Vacutainers™. Baseline (reference) plasma glucose measurements were undertaken on samples prepared under refrigerated conditions. The remaining samples underwent a series of controlled pre-analytical delays in sample preparation, at room temperature. Plasma glucose was measured using the hexokinase method.
RESULTS: Median baseline glucose (mmol/L) for the 62 participants was 10.6 (range 3.4-31.1). Using lithium heparin PST™ tubes, mean glucose loss (95% CI) was 0.16 (0.09-0.23) after 30 min delay in plasma preparation and 0.28 (0.21-0.34) after 60 min delay. Glucose loss was independent of both baseline glucose and also individual cellular count. Fluoride failed to inhibit glucose loss within the first hour after sample collection. Immediate plasma centrifugation of PST™ tubes, followed by delayed plasma extraction (median delay 92 min), produced a mean glucose loss of 0.02 mmol/L (-0.05-0.09).
CONCLUSIONS: Samples collected into lithium heparin PST™ tubes show pre-analytical glucose loss at 1 h that is independent of baseline glucose and cellular count. Furthermore, immediate plasma separation using these tubes attenuates glucose loss across a wide range of glucose concentrations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24706432     DOI: 10.1515/cclm-2013-1059

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  4 in total

1.  Real-World Gestational Diabetes Screening: Problems with the Oral Glucose Tolerance Test in Rural and Remote Australia.

Authors:  Emma L Jamieson; Erica P Spry; Andrew B Kirke; David N Atkinson; Julia V Marley
Journal:  Int J Environ Res Public Health       Date:  2019-11-14       Impact factor: 3.390

2.  Investigation of the Relationship between the Mid_Thigh Adipose Tissue Distribution Measured by MRI and Serum Osteocalcin-A Sex-Based Approach.

Authors:  Eva Hassler; Gunter Almer; Gernot Reishofer; Hannes Deutschmann; Wilfried Renner; Markus Herrmann; Stefan Leber; Alexander Staszewski; Felix Gunzer; Harald Mangge
Journal:  Nutrients       Date:  2021-12-27       Impact factor: 5.717

Review 3.  The Oral Glucose Tolerance Test-Is It Time for a Change?-A Literature Review with an Emphasis on Pregnancy.

Authors:  Delia Bogdanet; Paula O'Shea; Claire Lyons; Amir Shafat; Fidelma Dunne
Journal:  J Clin Med       Date:  2020-10-27       Impact factor: 4.241

4.  Maternal Obesity Affects the Glucose-Insulin Axis During the First Trimester of Human Pregnancy.

Authors:  Julia Bandres-Meriz; Anna M Dieberger; Denise Hoch; Caroline Pöchlauer; Martina Bachbauer; Andreas Glasner; Tobias Niedrist; Mireille N M van Poppel; Gernot Desoye
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-09       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.